Far-UVC leaves the lab: Hyundai and Kia disinfect the occupied car cabin

Until now, Far-UVC has been a ceiling business: KrCl excimer lamps and the first Far-UVC LEDs hang in hospital corridors, offices and waiting rooms — spaces where you keep some distance from the source. Hyundai and Kia flipped the problem and put the source into the tightest occupied space in everyday life: the car cabin, with people directly beneath it. On 24 June the two groups unveiled "Plasma Care UVC," claimed as the first in-vehicle disinfection system designed to run while passengers are inside.

What Hyundai and Kia built

The system works with Far-UVC in the 200–230 nm band. The light is produced by a plasma lamp followed by an optical filter that restricts emission to the controlled Far-UVC window, plus hardening against vehicle vibration and temperature swings. In a simulated 8 m³ cabin chamber the Korea Testing Laboratory confirmed a 96.8 % reduction in airborne viruses within 30 minutes; joint research with Seoul National University achieved 99.9 % eradication of pneumonia-causing bacteria after 30 seconds of Far-UVC exposure. It was validated in chamber, component and vehicle tests in a Kia PV5. Important caveat for context: the system is explicitly still in development, with no production application announced.

Why 200–230 nm works with people in the room

The difference between conventional UV-C (254 nm, allowed only in empty rooms) and Far-UVC is penetration depth. Light at 200–230 nm is absorbed so strongly in biological tissue that it essentially stops in the outermost, dead layer of skin (the stratum corneum) and in the tear film or outermost corneal layer of the eye — it barely reaches living cell layers. Bacteria and viruses have no such protective shell; their genetic material sits right in the beam. That limited penetration is the scientific basis on which the occupational-exposure body ACGIH raised its limits in 2022 for the first time in decades, evaluating skin and eye separately: roughly 479 mJ/cm² for skin and about 160 mJ/cm² for the eye at 222 nm. The eye, in other words, is the stricter yardstick — a point that matters in a moment.

The plasma lamp — a third source type

Far-UVC has so far come from two sources: filtered KrCl excimer lamps (a line at 222 nm) and the newer Far-UVC LEDs. A filtered plasma lamp is a third route into the same wavelength window. The filter is not decoration but part of the safety concept: Hyundai describes it explicitly as the component that restricts emission to the controlled Far-UVC range — a hint that the raw source also emits outside that safe window and would not be occupant-grade without filtering. Which of the three source types suits a tight cabin best is an open engineering question; what matters is that the source hits the narrow window cleanly and stably.

The three things the press release doesn't emphasise

The physics holds — but three points decide whether 96.8 % in the lab becomes real hygiene in the back seat.

1. Ozone. Light below roughly 230 nm splits oxygen and forms ozone. Peer-reviewed measurements on 222 nm lamps find production rates around 1040 µg/h and steady-state increases of 5–21 µg/m³, strongly dependent on ventilation and room size. A car cabin is tiny at ~8 m³, and a parked vehicle barely ventilates — ozone build-up is a real design factor here, manageable through airflow but not automatically zero.

2. Eye before skin. As above: the eye has the roughly three-times-lower limit. In a confined interior, with partly direct line of sight to the source, dose geometry matters more for the eyes than for the skin. That is exactly what the optical filter is for — and exactly where the validation burden lies.

3. A chamber is not a cabin. The 96.8 % and 99.9 % figures come from chamber and component tests with uniform irradiation. A real cabin has seats, consoles, legs, bags — geometry that casts shadows and distributes the dose unevenly. We described the same gap recently for hospital UV-C surface disinfection: the shadowed spot doesn't get the dose the chamber figure promises. The honest metric isn't the peak value but the dose at the worst-lit point.

What it means

"Plasma Care UVC" is less a finished feature than a signal: Far-UVC is leaving the ceiling fixture and aiming at tight, shared spaces where hygiene between rotating users counts — taxis, car-sharing, autonomous shuttles, purpose-built vehicles. The technology behind it is real and soundly reasoned; the open questions are engineering and validation questions — ozone management, eye geometry, real-world dose distribution — not physics questions. That Hyundai and Kia say "in development" rather than naming a launch date is exactly the right order of operations: prove the dose at the worst seat first, then build it in.